Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

St. Luke's-Roosevelt Hospital Center

ClinicalTrials.gov Identifier:

NCT01401374

First received: July 21, 2011

Last updated: April 7, 2017

Last verified: April 2017

History of Changes

Purpose

The study is an on-line survey posted on survey monkey that addresses some demographic and environmental issues that could potentially relate to vitiligo vulgaris onset or disease exacerbation.

Condition
Vitiligo Vulgaris


Study Type:	Observational
Study Design:	Observational Model: Other Time Perspective: Other
Official Title:	Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo

Resource links provided by NLM:

Genetics Home Reference related topics: vitiligo

MedlinePlus related topics: Vitiligo

Genetic and Rare Diseases Information Center resources: Hypomelanotic Disorder

U.S. FDA Resources

Further study details as provided by St. Luke's-Roosevelt Hospital Center:

Primary Outcome Measures:

Correlation of Disease State in Vitiligo with Clinical and Psychological Measures [ Time Frame: Self-reported retrospective single survey ]


Enrollment:	3258
Study Start Date:	March 2011
Study Completion Date:	March 2016
Primary Completion Date:	March 2016 (Final data collection date for primary outcome measure)

Groups/Cohorts
Vitiligo Patients patients with vitiligo vulgaris
Controls Individuals without vitiligo vulgaris

Detailed Description:

The survey is designed to look at some issues that are pertinent to individuals with vitiligo, including access to care, severity of disease, under-reported disease activity, causative and exacerbating factors and co-morbid illnesses.

Eligibility


Ages Eligible for Study:	Child, Adult, Senior
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	Yes
Sampling Method:	Non-Probability Sample

Study Population

Individuals self-reporting vitiligo vulgaris and controls who do not have vitiligo vulgaris

Criteria

Inclusion Criteria:

Ability to complete survey

Exclusion Criteria:

Inability to complete survey

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01401374

Locations


United States, New York
St. Luke's-Roosevelt Hospital Center
New york, New York, United States, 10025

Sponsors and Collaborators

St. Luke's-Roosevelt Hospital Center

Investigators


Principal Investigator:	Nanette Silverberg, MD	St. Luke's-Roosevelt Hospital Center

More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Silverberg JI, Reja M, Silverberg NB. Regional variation of and association of US birthplace with vitiligo extent. JAMA Dermatol. 2014 Dec;150(12):1298-305.

Silverberg JI, Silverberg NB. Quality of life impairment in children and adolescents with vitiligo. Pediatr Dermatol. 2014 May-Jun;31(3):309-18. doi: 10.1111/pde.12226. Epub 2013 Oct 18.

Silverberg JI, Silverberg NB. Association between vitiligo extent and distribution and quality-of-life impairment. JAMA Dermatol. 2013 Feb;149(2):159-64.


Responsible Party:	St. Luke's-Roosevelt Hospital Center
ClinicalTrials.gov Identifier:	NCT01401374 History of Changes
Other Study ID Numbers:	10-148/10-149x
Study First Received:	July 21, 2011
Last Updated:	April 7, 2017

Keywords provided by St. Luke's-Roosevelt Hospital Center:


Vitiligo Vulgaris Autoimmunity Thyroid Disease

Additional relevant MeSH terms:


Vitiligo Hypopigmentation Pigmentation Disorders Skin Diseases

ClinicalTrials.gov processed this record on August 18, 2017

To Top